Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Lupus ; 29(10): 1263-1269, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32646294

ABSTRACT

OBJECTIVES: Clinical and laboratory investigations have revealed that Epstein-Barr virus (EBV) is involved in altered immunological response of systemic lupus erythematosus (SLE). Higher seroprevalence rates of anti-EBV antibodies and increased viral load are demonstrated in adult SLE patients. The prevalence of BK polyomavirus (BKV) reactivation is also suggested to be higher in SLE. Herein, we aimed to evaluate the immune response of children with SLE to EBV antigens in addition to EBV and BKV DNA. We also tried to evaluate whether these serological results differ from another connective tissue disease - juvenile systemic sclerosis (jSS) - and healthy individuals. METHODS: Serum levels of EBV early antigen diffuse (EA-D) IgG, EBV nuclear antigen-1 IgG, EBV viral capsid antigen (VCA), cytomegalovirus (CMV) IgG, EBV DNA, CMV DNA and urinary BKV DNA were evaluated in healthy controls and in patients with a diagnosis of juvenile SLE (jSLE) and jSS. RESULTS: A total of 70 jSLE patients, 14 jSS patients and 44 sex-matched healthy individuals were involved in the study. EBV VCA was positive in 84.2% of jSLE patients, 85.7% of jSS patients and 36.3% of healthy controls. EBV EA-D IgG positivity was significantly higher in jSLE patients compared to jSS patients and healthy controls (20% vs. 7.1% and 0%, p = 0.005). EBV VCA positivity was associated with malar rash and immunological disorder, but there was no statistical significance in other antibody positivity in terms of clinical and haemogram findings and autoantibody positivity. CMV DNA positivity was present in only 2.8% of jSLE patients. None of the jSS patients or the healthy controls had CMV DNA positivity. EBV DNA and BKV DNA were also negative in all three groups. CONCLUSION: The results of our study assume a relationship between SLE and EBV, but we could not demonstrate an association between CMV and BKV. The negative DNA results in contrast to serological positivity can be interpreted as an altered and impaired immune system and increased viral susceptibility. These results suggest that EBV contributes to disease continuity, even if it does not directly cause development.


Subject(s)
Herpesvirus 4, Human/immunology , Lupus Erythematosus, Systemic/virology , Adolescent , Adult , Antibodies, Viral/blood , Antigens, Viral/blood , Antigens, Viral/immunology , BK Virus/immunology , BK Virus/isolation & purification , Capsid Proteins/immunology , Case-Control Studies , Child , Cytomegalovirus/immunology , Cytomegalovirus/isolation & purification , Disease Progression , Epstein-Barr Virus Infections , Herpesvirus 4, Human/isolation & purification , Humans , Lupus Erythematosus, Systemic/blood , Scleroderma, Localized/blood , Scleroderma, Localized/virology , Scleroderma, Systemic/blood , Scleroderma, Systemic/virology , Viral Load , Young Adult
2.
Med Sci Monit ; 23: 505-512, 2017 Jan 28.
Article in English | MEDLINE | ID: mdl-28130554

ABSTRACT

BACKGROUND Morphea, also known as localized scleroderma, is a rare autoimmune connective tissue disease characterized by skin fibrosis. UVA1 phototherapy is an important asset in the reduction of clinical manifestations in morphea. There are studies claiming that UV light modulates the expression of some human endogenous retroviral sequences. The aim of this study was to determine if the expression of HERV-K10 gag element is lowered by UVA1 phototherapy in morphea, a disease in which such irradiation has a soothing effect. MATERIAL AND METHODS The expression levels of the HERV-K10 gag were assessed by real-time PCR (polymerase chain reaction) in peripheral blood mononuclear cells (PBMC) and skin-punch biopsies of healthy volunteers and 9 morphea patients before and after phototherapy. Additionally, correlations between the HERV-K10 gag expression and age, disease duration, the Localized Scleroderma Skin Severity Index (LoSSI), and antinuclear antibody (ANA) titers were assessed. RESULTS In PBMC, HERV-K10 gag mRNA was significantly elevated after UVA1 phototherapy compared to healthy controls. Most of the patients responded with an increased expression level of this sequence. However, we found no statistical evidence at this point that phototherapy indeed has an effect on the HERV-K10 gag expression (there were no statistical differences in PBMC of morphea patients before and after phototherapy). Similarly, there was no statistically relevant effect of the UVA1 on the expression of HERV-K10 gag in skin. CONCLUSIONS At this point, the effect of UVA1 phototherapy on the expression of HERV-K10 gag cannot be statistically confirmed.


Subject(s)
Endogenous Retroviruses/radiation effects , Gene Products, gag/biosynthesis , Retroviridae Infections/therapy , Scleroderma, Localized/therapy , Ultraviolet Therapy/methods , Adult , Aged , Case-Control Studies , Endogenous Retroviruses/genetics , Endogenous Retroviruses/metabolism , Female , Gene Products, gag/genetics , Gene Products, gag/metabolism , Humans , Leukocytes, Mononuclear/radiation effects , Male , Middle Aged , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Retroviridae Infections/blood , Retroviridae Infections/pathology , Retroviridae Infections/virology , Scleroderma, Localized/blood , Scleroderma, Localized/pathology , Scleroderma, Localized/virology , Ultraviolet Rays
5.
Br J Dermatol ; 150(6): 1091-5, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15214893

ABSTRACT

BACKGROUND: Human parvovirus B19 is a small, single-stranded DNA virus encoding two structural capsid proteins and a nonstructural protein. It is the aetiological agent of erythema infectiosum and transient aplastic crisis in patients with haemolytic anaemia, and has been associated with fetal death, arthritis and chronic anaemia. In recent years, the possible involvement of parvovirus B19 in systemic sclerosis (SSc) has been reported. OBJECTIVES: To determine whether human parvovirus B19 DNA can be detected in SSc skin tissue specimens. METHODS: Normal subjects (n = 97) and patients with SSc (n = 48), systemic lupus erythematosus (n = 16), dermatomyositis (n = 8), morphoea (n = 6) and graft-versus-host disease (n = 8) were studied. Crude DNA was extracted from skin tissue specimens. We attempted to determine whether human parvovirus B19 could be detected in the skin of SSc using nested polymerase chain reaction (PCR). PCR amplification was performed with specifically designed first and second primer pairs for parvovirus B19 DNA. RESULTS: After the first PCR, the occurrence rate of parvovirus B19 DNA in SSc skin tissues (36 of 48, 75%) was significantly elevated in comparison with that in normal controls (50 of 97, 52%) (P < 0.01). After the second PCR, the occurrence rate of parvovirus B19 DNA in SSc skin tissues (36 of 48, 75%) was significantly elevated compared with that in normal controls (53 of 97, 55%) (P < 0.02). The occurrence rates in the other diseases showed no significant difference from that in normal controls. CONCLUSIONS: The increased prevalence of human parvovirus B19 DNA in SSc skin showed the possibility that the virus may be involved in the formation of skin tissue abnormalities in the disease.


Subject(s)
Parvoviridae Infections/complications , Parvovirus B19, Human/isolation & purification , Scleroderma, Systemic/virology , Skin/virology , Adult , Aged , Case-Control Studies , Chi-Square Distribution , DNA, Viral/analysis , Dermatomyositis/virology , Female , Graft vs Host Disease , Humans , Lupus Erythematosus, Systemic/virology , Male , Middle Aged , Parvoviridae Infections/diagnosis , Parvovirus B19, Human/genetics , Polymerase Chain Reaction/methods , Prevalence , Scleroderma, Localized/virology , Viral Load
7.
Clin Exp Dermatol ; 28(4): 380-2, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12823298

ABSTRACT

A 62-year-old Japanese man presented with multiple small atrophic macules on the trunk and extremities. The lesions were discrete, oval in shape and enclosed by lilac ring. They were distributed in a Christmas tree distribution, reminiscent of pityriasis rosea. Skin biopsy showed increased collagen fibres in the dermis and invading subcutaneous tissue. The clinico-pathological features were consistent with guttate morphoea, a rare variant of localized scleroderma. Serological tests revealed a positive reaction to human T-cell lymphoma/lymphotropic virus type-1 infection.


Subject(s)
Leukemia-Lymphoma, Adult T-Cell/complications , Scleroderma, Localized/virology , Skin Diseases, Viral/complications , Biopsy , Collagen Type I/metabolism , Human T-lymphotropic virus 1 , Humans , Male , Middle Aged , Scleroderma, Localized/pathology , Serologic Tests , Transforming Growth Factor beta , Transforming Growth Factor beta1
8.
J Am Acad Dermatol ; 39(5 Pt 2): 824-6, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9810907

ABSTRACT

Hepatitis C virus (HCV) is a common cause of chronic hepatitis and is frequently associated with extrahepatic disease. Recently, cutaneous disorders have been a presenting manifestation of HCV infection. Porphyria cutanea tarda (PCT) is one of the cutaneous diseases associated with hepatitis C. PCT manifests in an acute form with tense bullae and erosions and in a chronic form with milia, scarring, and sclerodermatous changes. HCV has also been implicated as a cause of vasculitis through immune complex deposition. We report a patient in whom HCV was associated with sclerodermoid PCT and a medium vessel vasculitis. This case underscores the importance of HCV and its potential cutaneous manifestations, as well as the importance of recognizing cutaneous manifestations of internal disease that may be the first clue to diagnosis of HCV.


Subject(s)
Alopecia/virology , Hepatitis C/complications , Porphyria Cutanea Tarda/virology , Scalp Dermatoses/virology , Scleroderma, Localized/virology , Aged , Cicatrix/virology , Female , Humans , Hyperpigmentation/virology , Hypopigmentation/virology , Skin Diseases, Vascular/virology , Vasculitis/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...